Literature DB >> 20508596

Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.

B Isemann1, J Meinzen-Derr, H Akinbi.   

Abstract

OBJECTIVE: To identify maternal and neonatal factors that impact response to methadone therapy for neonatal abstinence syndrome. STUDY
DESIGN: This is a retrospective review of 128 infants that received pharmacotherapy for opiate withdrawal to identify factors associated with favorable response to methadone therapy. Maternal and neonatal data were analyzed with univariate statistics and multivariate logistic regression. RESULT: Maternal methadone maintenance dose during pregnancy correlated with length of stay (P=0.009). There was an inverse correlation between the amount of mother's breast milk ingested and length of stay (β=-0.03, P=0.02). Methadone was initiated later, tapered more rapidly and was more successful as monotherapy in preterm infants. Five percent of infants were admitted to hospital again for rebound withdrawal following reduction of breast milk intake.
CONCLUSION: Severity of neonatal abstinence syndrome may be mitigated by titrating methadone to the lowest effective dose during pregnancy and by encouraging breast milk feeds, which should be weaned gradually.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508596     DOI: 10.1038/jp.2010.66

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  17 in total

1.  Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis.

Authors:  Kathryn Dee L MacMillan; Cassandra P Rendon; Kanak Verma; Natalie Riblet; David B Washer; Alison Volpe Holmes
Journal:  JAMA Pediatr       Date:  2018-04-01       Impact factor: 16.193

Review 2.  Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).

Authors:  A K Mangat; G M Schmölzer; W K Kraft
Journal:  Semin Fetal Neonatal Med       Date:  2019-02-05       Impact factor: 3.926

3.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

4.  Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.

Authors:  C H Backes; C R Backes; D Gardner; C A Nankervis; P J Giannone; L Cordero
Journal:  J Perinatol       Date:  2011-08-18       Impact factor: 2.521

Review 5.  Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.

Authors:  Erin Kelty; David B Preen
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

6.  An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome.

Authors:  Matthew R Grossman; Adam K Berkwitt; Rachel R Osborn; Yaqing Xu; Denise A Esserman; Eugene D Shapiro; Matthew J Bizzarro
Journal:  Pediatrics       Date:  2017-05-18       Impact factor: 7.124

7.  Lactose-free infant formula does not change outcomes of neonatal abstinence syndrome (NAS): a randomized clinical trial.

Authors:  Rajesh Pandey; Neelakanta Kanike; Mugahid Ibrahim; Namita Swarup; Dennis M Super; Sharon Groh-Wargo; Deepak Kumar
Journal:  J Perinatol       Date:  2020-08-31       Impact factor: 2.521

8.  Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.

Authors:  Tess Flannery; Jonathan M Davis; Adam J Czynski; Lynne M Dansereau; Erica L Oliveira; Samantha A Camardo; Barry M Lester
Journal:  J Pediatr       Date:  2020-08-14       Impact factor: 4.406

9.  Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.

Authors:  Jason R Wiles; Barbara Isemann; Laura P Ward; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2014-06-16       Impact factor: 4.406

10.  Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients.

Authors:  Brooks T McPhail; Chie Emoto; Tsuyoshi Fukuda; Dawn Butler; Jason R Wiles; Henry Akinbi; Alexander A Vinks
Journal:  J Clin Pharmacol       Date:  2019-12-09       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.